Novozymes A/S: Novozymes' and Chr. Hansen's shareholders approve combination to create a leading global biosolutions partner

The proposed combination of Novozymes and Chr. Hansen has now been approved by each company's respective shareholders, and with strong support from the shareholders the two biosolutions companies

Related Keywords

United States ,Copenhagen ,Køavn ,Denmark ,Danish ,Ester Baiget ,Dominique Reiniche ,Mauricio Graber ,Lina Danstrup ,Head Of External Communications ,International Financial Reporting Standards ,Exchange Commission ,World Economic Forum ,Novozymes Group ,Hansen Group ,Hansen Holding ,Purchase Price Allocation ,Investor Relations ,United States Securities Act ,Securities Act ,Novozymes ,Ansen ,Shareholders ,Pprove ,Combination ,Create ,Reading ,Lobal ,Ibiosolutions ,Partner ,